熱門資訊> 正文
CEL-SCI股价因拟议公开募股而下跌
2025-08-28 05:32
- CEL-SCI Corporation (NYSE:CVM) said on Wednesday that it intends to offer to sell shares of its common stock in a best-efforts public offering.
- All of the shares of common stock are being offered by the company.
- The company intends to use the net proceeds from this offering to fund the continued development of Multikine, for general corporate purposes, and working capital.
- Shares of CEL-SCI (NYSE:CVM) fell more than 24% in extended trading.
More on Cel-Sci
- CEL-SCI announces pricing of $5.7 million offering
- Seeking Alpha’s Quant Rating on Cel-Sci
- Historical earnings data for Cel-Sci
- Financial information for Cel-Sci
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
